Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Farmers Insurance
UBS
Federal Trade Commission
Fuji
Covington
QuintilesIMS
US Army

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087724

« Back to Dashboard

NDA 087724 describes ANGIOVIST 292, which is a drug marketed by Bayer Hlthcare and is included in one NDA. Additional details are available on the ANGIOVIST 292 profile page.

The generic ingredient in ANGIOVIST 292 is diatrizoate meglumine; diatrizoate sodium. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for 087724
Tradename:ANGIOVIST 292
Applicant:Bayer Hlthcare
Ingredient:diatrizoate meglumine; diatrizoate sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength52%;8%
Approval Date:Sep 23, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Harvard Business School
Moodys
UBS
Chubb
Baxter
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.